Inaktiver Wert

Kun Run Biotechnology, Inc. Aktie

Aktien

Dauer

Zeitraum

Stil

KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration	17.06.10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement	22.04.10
KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results	30.03.10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results	13.11.09
KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million	01.04.09

Sektor

	% 1. Jan.	Kap.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22,08 %	44,25 Mrd.
OTSUKA HOLDINGS CO., LTD.	+19,80 %	22,33 Mrd.
CIPLA LIMITED	+10,34 %	13,36 Mrd.
SANDOZ GROUP AG	+3,22 %	13,24 Mrd.
ZYDUS LIFESCIENCES LIMITED	+37,09 %	11,27 Mrd.
ONO PHARMACEUTICAL CO., LTD.	-6,38 %	7,15 Mrd.
THE MEDICINES COMPANY	-0,05 %	6,79 Mrd.
STADA ARZNEIMITTEL	-8,87 %	5,73 Mrd.
ASPEN PHARMACARE HOLDINGS LIMITED	+10,00 %	5,24 Mrd.